Bachaar Arnaout, MD
Research & Publications
Biography
News
Coauthors
Selected Publications
- CannabinoidsDe Aquino J, Arnaout B. Cannabinoids. 2020, 153-167. DOI: 10.1007/978-3-030-33404-8_10.
- Brief Training on Medication-Assisted Treatment Improves Community Mental Health Clinicians’ Confidence and Readiness to Address Substance Use DisordersIheanacho T, Bommersbach T, Fuehrlein B, Arnaout B, Dike C. Brief Training on Medication-Assisted Treatment Improves Community Mental Health Clinicians’ Confidence and Readiness to Address Substance Use Disorders. Community Mental Health Journal 2020, 56: 1429-1435. PMID: 32062717, PMCID: PMC7429311, DOI: 10.1007/s10597-020-00586-8.
- Alcohol withdrawal hallucinations in the general population, an epidemiological studyStephane M, Arnaout B, Yoon G. Alcohol withdrawal hallucinations in the general population, an epidemiological study. Psychiatry Research 2018, 262: 129-134. PMID: 29433107, DOI: 10.1016/j.psychres.2018.02.021.
- Description of a Comprehensive Addiction Rotation at a Psychiatry Residency ProgramArnaout B, Muvvala S, Rohrbaugh R, Petrakis I. Description of a Comprehensive Addiction Rotation at a Psychiatry Residency Program. Academic Psychiatry 2018, 42: 313-316. PMID: 29302930, DOI: 10.1007/s40596-017-0858-2.
- Effective Switch From Clozapine to Aripiprazole in Treatment-Resistant Schizophrenia and Comorbid Alcohol Use DisorderFeeley RJ, Arnaout B, Yoon G. Effective Switch From Clozapine to Aripiprazole in Treatment-Resistant Schizophrenia and Comorbid Alcohol Use Disorder. Journal Of Clinical Psychopharmacology 2017, 37: 729-730. PMID: 29028689, DOI: 10.1097/jcp.0000000000000794.
- Motivational Interviewing for Clinical Practice: Just Do ItMarienfeld, C, Arnaout, B, Levounis, P. Motivational Interviewing for Clinical Practice: Just Do It. Psychiatric News 2017, 52: 1-1. DOI: 10.1176/appi.pn.2017.3a20.
- Motivational Interviewing for Clinical PracticeLevounis P, Arnaout B, Marienfeld C. Motivational Interviewing for Clinical Practice. 2017 DOI: 10.1176/appi.books.9781615371860.
- Mecamylamine for Treatment of People With Dual Diagnoses of Depression and Alcohol DependenceRalevski E, Jane J, O’Brien E, Edens E, Arnaout B, Kerfoot K, Keegan K, Weiner J, Russo M, Petrakis I. Mecamylamine for Treatment of People With Dual Diagnoses of Depression and Alcohol Dependence. Journal Of Dual Diagnosis 2013, 9: 301-310. DOI: 10.1080/15504263.2013.835163.
- Treatment With Acamprosate in Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol DependenceRalevski E, O’Brien E, Jane JS, Dwan R, Dean E, Edens E, Arnaout B, Keegan K, Drew S, Petrakis I. Treatment With Acamprosate in Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence. Journal Of Dual Diagnosis 2011, 7: 64-73. PMID: 26954912, DOI: 10.1080/15504263.2011.569440.
- Sedative-Hypnotics and AnxiolyticsArnaout B, Petrakis I. Sedative-Hypnotics and Anxiolytics. 2010, 511-523. DOI: 10.1007/978-1-4419-0338-9_23.
- Escitalopram versus placebo in the treatment of dysthymic disorderHellerstein DJ, Batchelder ST, Hyler S, Arnaout B, Toba C, Benga I, Gangure D. Escitalopram versus placebo in the treatment of dysthymic disorder. International Clinical Psychopharmacology 2010, 25: 143-148. PMID: 21811192, DOI: 10.1097/yic.0b013e328333c35e.
- Does a History of Alcohol Use Disorder Affect Response to Antidepressant Medication in Patients With Dysthymic Disorder?Arnaout B, Batchelder S, Rosenthal R, Hyler S, Hellerstein D. Does a History of Alcohol Use Disorder Affect Response to Antidepressant Medication in Patients With Dysthymic Disorder? Journal Of Dual Diagnosis 2008, 4: 377-393. DOI: 10.1080/15504260802086842.
- Diagnosing co-morbid drug use in patients with alcohol use disorders.Arnaout B, Petrakis IL. Diagnosing co-morbid drug use in patients with alcohol use disorders. Alcohol Research 2008, 31: 148-54. PMID: 23584816, PMCID: PMC3860455.
- Aripiprazole as an adjunctive treatment for refractory unipolar depressionHellerstein DJ, Batchelder S, Hyler S, Arnaout B, Corpuz V, Coram L, Weiss G. Aripiprazole as an adjunctive treatment for refractory unipolar depression. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2007, 32: 744-750. PMID: 18164528, DOI: 10.1016/j.pnpbp.2007.11.024.